A Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature Assay

The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer

NCT02653755 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

NCT00898014 ·Status: COMPLETED

A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer

NCT01423890 ·Status: COMPLETED ·Phase: NA

A Study to Identify Breast Cancer (IDBC)

NCT04495244 ·Status: UNKNOWN

Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

NCT02078570 ·Status: UNKNOWN

Identification of New Prognostic Markers for Breast Cancer.

NCT03436069 ·Status: RECRUITING

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

NCT06979921 ·Status: ACTIVE_NOT_RECRUITING

Genomic Signatures to Predict Treatment Response

NCT02032745 ·Status: COMPLETED

Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer

NCT02875626 ·Status: COMPLETED ·Phase: NA

Early Detection of Breast Cancer

NCT06043661 ·Status: RECRUITING

Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer

NCT03786575 ·Status: UNKNOWN ·Phase: NA

BIOPSY SCANNER LLTECH© Technology for Diagnosis of Breast Cancer

NCT04292821 ·Status: UNKNOWN

Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG

NCT03579979 ·Status: COMPLETED ·Phase: NA

Utilization of Genomic Signature as Decision-making for Adjuvant Treatment of Breast Cancer

NCT00912080 ·Status: UNKNOWN ·Phase: NA

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

NCT07219277 ·Status: RECRUITING

Implementation of Solid Digital PCR to Support Gold-standard Methods for Evaluation of HER2 Amplification Status: Focus on HER2-low Subtype

NCT06813456 ·Status: RECRUITING

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

NCT01839045 ·Status: UNKNOWN

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

NCT05721326 ·Status: COMPLETED ·Phase: NA

InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2

NCT05835739 ·Status: RECRUITING

Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI

NCT05800132 ·Status: RECRUITING ·Phase: NA

Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast Cancer

NCT01247480 ·Status: UNKNOWN

Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy

NCT01140776 ·Status: TERMINATED

Clinical Application of ctDNA in Early Screening of Breast Cancer

NCT03973034 ·Status: UNKNOWN

Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer

NCT03920488 ·Status: UNKNOWN

Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer

NCT00293865 ·Status: COMPLETED ·Phase: NA